Intersecting epidemics of HIV, HCV, and syphilis among soon-to-be released prisoners in Kyrgyzstan: Implications for prevention and treatment

International Journal of Drug Policy

Volumn 37, Issue , 2016, Pages 9-20

  Azbel, Lyuba ^b   Polonsky, Maxim ^b   Wegman, Martin ^c   Shumskaya, Natalya ^d   Kurmanalieva, Ainura ^d   Asanov, Akylbek ^e   Wickersham, Jeffrey A ^b,f   Dvoriak, Sergii ^g   Altice, Frederick L ^b,f,h  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF FLORIDA   (United States)

^d AIDS Foundation East West   (Kyrgyzstan)

^e Department for Medical and Sanitary Services of the State Service on Penalty Execution ^*  (Kyrgyzstan)

^f UNIVERSITY OF MALAYA   (Malaysia)

^g UKRAINIAN INSTITUTE ON PUBLIC HEALTH POLICY   (Ukraine)

^h YALE UNIVERSITY   (United States)

Author keywords

HIV prevalence; Kyrgyzstan; Opioid use disorders; People who inject drugs (PWID); Prisons; Syphilis

Indexed keywords

OPIATE;

ADULT; AGED; ARTICLE; BEHAVIOR ASSESSMENT; EPIDEMIC; FEMALE; HEALTH SURVEY; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; KYRGYZSTAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MORBIDITY; OFFENDER; OPIATE ADDICTION; PREVALENCE; PRIORITY JOURNAL; PRISON; PRISONER; SEX DIFFERENCE; SUBSTANCE USE; SYPHILIS; CLINICAL TRIAL; CROSS-SECTIONAL STUDY; MIDDLE AGED; MIXED INFECTION; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; ODDS RATIO; RISK FACTOR; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA; SUBSTANCE ABUSE; YOUNG ADULT;

ADULT; AGED; COINFECTION; CROSS-SECTIONAL STUDIES; EPIDEMICS; FEMALE; HEPATITIS C; HIV INFECTIONS; HUMANS; KYRGYZSTAN; LINEAR MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; OPIOID-RELATED DISORDERS; PREVALENCE; PRISONERS; RISK FACTORS; SUBSTANCE ABUSE, INTRAVENOUS; SYPHILIS; YOUNG ADULT;

EID: 84989812009     PISSN: 09553959     EISSN: 18734758     Source Type: Journal    
DOI: 10.1016/j.drugpo.2016.06.007     Document Type: Article

References (88)

1. Altice, F.L., Sullivan, L.E., Smith-Rohrberg, D., Basu, S., Stancliff, S., Eldred, L., The potential role of buprenorphine in the treatment of opioid dependence in HIV-infected individuals and in HIV infection prevention. Clinical Infectious Diseases 43:Suppl. 4 (2006), S178–S183, 10.1086/508181 pii:CID40075.
2. Altice, F.L., Kamarulzaman, A., Soriano, V.V., Schechter, M., Friedland, G.H., Treatment of medical, psychiatric, and substance-use comorbidities in people infected with HIV who use drugs. Lancet 376:9738 (2010), 367–387, 10.1016/s0140-6736(10)60829-x.
3. Altice, F.L., Bruce, R.D., Lucas, G.M., Lum, P.J., Korthuis, P.T., Flanigan, T.P., et al. HIV treatment outcomes among HIV-infected, opioid-dependent patients receiving buprenorphine/naloxone treatment within HIV clinical care settings: Results from a multisite study. Journal of Acquired Immune Deficiency Syndromes 56:Suppl. 1 (2011), S22–S32, 10.1097/QAI.0b013e318209751e.
4. Altice, F.L., Bruce, R.D., Lucas, G.M., Lum, P.J., Korthuis, P.T., Flanigan, T.P., et al. HIV treatment outcomes among HIV-infected, opioid-dependent patients receiving buprenorphine/naloxone treatment within HIV clinical care settings: Results from a multisite study. Journal of Acquired Immune Deficiency Syndromes 1:56 (Suppl.) (2011), S22–S32, 10.1097/QAI.0b013e318209751e.
5. Ancker, S., Rechel, B., HIV/AIDS policy-making in Kyrgyzstan: A stakeholder analysis. Health Policy and Planning 30:1 (2015), 8–18, 10.1093/heapol/czt092.
6. Azbel, L., Wickersham, J.A., Grishaev, Y., Dvoryak, S., Altice, F.L., Burden of infectious diseases, substance use disorders, and mental illness among Ukrainian prisoners transitioning to the community. PLOS ONE, 8(3), 2013, e59643, 10.1371/journal.pone.0059643.
7. Azbel, L., Wickersham, J.A., Wegman, M.P., Polonsky, M., Suleymanov, M., Ismayilov, R., et al. Burden of substance use disorders, mental illness, and correlates of infectious diseases among soon-to-be released prisoners in Azerbaijan. Drug and Alcohol Dependence 151 (2015), 68–75, 10.1016/j.drugalcdep.2015.02.034.
8. Baral, S., Todd, C.S., Aumakhan, B., Lloyd, J., Delegchoimbol, A., Sabin, K., HIV among female sex workers in the Central Asian Republics, Afghanistan, and Mongolia: Contexts and convergence with drug use. Drug and Alcohol Dependence 132:Suppl. 1 (2013), S13–S16, 10.1016/j.drugalcdep.2013.07.004.
9. Beletsky, L., Thomas, R., Shumskaya, N., Artamonova, I., Smelyanskaya, M., Police education as a component of national HIV response: Lessons from Kyrgyzstan. Drug and Alcohol Dependence 132:Suppl. 1 (2013), S48–S52, 10.1016/j.drugalcdep.2013.06.027.
10. Beyrer, C., Abdool Karim, Q., The changing epidemiology of HIV in 2013. Current Opinion in HIV and AIDS 8:4 (2013), 306–310, 10.1097/COH.0b013e328361f53a.
11. Bojko, M.J., Dvoriak, S., Altice, F.L., At the crossroads: HIV prevention and treatment for people who inject drugs in Ukraine. Addiction 108:10 (2013), 1697–1699, 10.1111/add.12243.
12. Boltaev, A., Deryabina, A., Howard, A., Aizberg, O., Assessment of the medication assisted therapy program in the Kyrgyz Republic. 2012.
13. Boltaev, A.A., El-Bassel, N., Deryabina, A.P., Terlikbaeva, A., Gilbert, L., Hunt, T., et al. Scaling up HIV prevention efforts targeting people who inject drugs in Central Asia: A review of key challenges and ways forward. Drug and Alcohol Dependence 132:Suppl. 1 (2013), S41–S47, 10.1016/j.drugalcdep.2013.07.033.
14. Branson, B.M., Handsfield, H.H., Lampe, M.A., Janssen, R.S., Taylor, A.W., Lyss, S.B., et al. Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR Recommendations and Reports 55:RR-14 (2006), 1–17 pii:rr5514a1.
15. Brislin, R.W., Back-translation for cross-cultural research. Journal of Cross-Cultural Psychology 1 (1970), 185–216.
16. Cakalo, J.I., Bozicevic, I., Vitek, C., Mandel, J.S., Salyuk, T., Rutherford, G.W., Misclassification of men with reported HIV infection in Ukraine. AIDS and Behavior, 2015, 10.1007/s10461-015-1112-0.
17. Centers for Disease Control and Prevention, HIV testing implementation guidance for correctional settings. 2009 Retrieved from http://www.cdc.gov/hiv/topics/testing/resources/guidelines/correctional-settings.
18. Degenhardt, L., Mathers, B., Vickerman, P., Rhodes, T., Latkin, C., Hickman, M., Prevention of HIV infection for people who inject drugs: Why individual, structural, and combination approaches are needed. Lancet 376:9737 (2010), 285–301, 10.1016/S0140-6736(10)60742-8 pii:S0140-6736(10)60742-8.
19. DeHovitz, J., Uuskula, A., El-Bassel, N., The HIV epidemic in Eastern Europe and Central Asia. Current HIV/AIDS Reports 11:2 (2014), 168–176, 10.1007/s11904-014-0202-3.
20. DiClemente, R.J., Davis, T.L., Swartzendruber, A., Fasula, A.M., Boyce, L., Gelaude, D., et al. Efficacy of an HIV/STI sexual risk-reduction intervention for African American adolescent girls in juvenile detention centers: A randomized controlled trial. Women and Health 54:8 (2014), 726–749, 10.1080/03630242.2014.932893.
21. Dukers-Muijrers, N.H., Somers, C., Hoebe, C.J., Lowe, S.H., Niekamp, A.M., Oude Lashof, A., et al. Improving sexual health for HIV patients by providing a combination of integrated public health and hospital care services: A one-group pre- and post test intervention comparison. BMC Public Health, 12, 2012, 1118, 10.1186/1471-2458-12-1118.
22. Eaton, W.W., MC, S.C., Tien, A., Ybarra, M., The use of psychological testing for treatment planning and outcomes assessment, Mawah, NJ. 3rd ed., 2004.
23. El-Bassel, N., Strathdee, S.A., El Sadr, W.M., HIV and people who use drugs in central Asia: Confronting the perfect storm. Drug and Alcohol Dependence 132:Suppl. 1 (2013), S2–S6, 10.1016/j.drugalcdep.2013.07.020.
24. Flanigan, T.P., Beckwith, C.G., Routine HIV testing in jails is critical for the early diagnosis of HIV infection in men. Clinical Infectious Diseases, 47(10), 2008, 1366, 10.1086/592754 [doi].
25. Flanigan, T., Zaller, N., Beckwith, C.G., Bazerman, L.B., Rana, A., Gardner, A., et al. Testing for HIV, sexually transmitted infections, and viral hepatitis in jails: Still a missed opportunity for public health and hiv prevention. Journal of Acquired Immune Deficiency Syndromes 55:55(Suppl. 2) (2010), S78–S83.
26. Fu, J.J., Herme, M., Wickersham, J.A., Zelenev, A., Althoff, A., Zaller, N.D., et al. Understanding the revolving door: Individual and structural-level predictors of recidivism among individuals with HIV leaving jail. AIDS and Behavior 17:Suppl. 2 (2013), S145–S155, 10.1007/s10461-013-0590-1.
27. Ghanem, K.G., Hutton, H.E., Zenilman, J.M., Zimba, R., Erbelding, E.J., Audio computer assisted self interview and face to face interview modes in assessing response bias among STD clinic patients. Sexually Transmitted Infections 81:5 (2005), 421–425, 10.1136/sti.2004.013193.
28. Gilbert, L., Primbetova, S., Nikitin, D., Hunt, T., Terlikbayeva, A., Momenghalibaf, A., et al. Redressing the epidemics of opioid overdose and HIV among people who inject drugs in Central Asia: The need for a syndemic approach. Drug and Alcohol Dependence 132:Suppl. 1 (2013), S56–S60, 10.1016/j.drugalcdep.2013.07.017.
29. Golembeski, C., Fullilove, R., Criminal (in)justice in the city and its associated health consequences. American Journal of Public Health 98:9 (Suppl.) (2008), S185–S190 Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/18687612.
30. Haig, T., Randomized controlled trial proves effectiveness of methadone maintenance treatment in prison. Canadian HIV/AIDS Policy & Law Review, 8(3), 2003, 48.
31. Herbert, L.J., Middleton, S.I., An estimate of syphilis incidence in Eastern Europe. Journal of Global Health, 2(1), 2012, 010402, 10.7189/jogh.02.010402.
32. International AIDS Society, Expanding access to opioid substitution therapy for injecting drug users in Eastern Europe and Central Asia. 2011 Retrieved from Bishkek Kyrgyzstan.
33. International Centre for Prison Studies, World prison brief. 2015 Retrieved from http://www.prisonstudies.org/country/kyrgyzstan.
34. Izenberg, J., Altice, F.L., Next steps for Ukraine – abolition of HIV registries, implementation of routine HIV testing and expansion of services. Addiction 105:3 (2010), 569–570 Retrieved from http://onlinelibrary.wiley.com/store/10.1111/j.1360-0443.2009.02881.x/asset/j.1360-0443.2009.02881.x.pdf?v=1&t=hqo22o1s&s=aca8439d955a5c6049fe04b93e4fd9f57c9b2b17.
35. Joint United Nations Programme on HIV/AIDS, UNAIDS report on the global AIDS epidemic 2012. Retrieved from Geneva, Switzerland, 2012.
36. Joint United Nations Programme on HIV/AIDS (UNAIDS), The gap report. (UNAIDS/JC2656), Geneva Switzerland, 2014.
37. Jurgens, R., Ball, A., Verster, A., Interventions to reduce HIV transmission related to injecting drug use in prison. Lancet Infectious Diseases 9:1 (2009), 57–66, 10.1016/S1473-3099(08)70305-0 pii:S1473-3099(08)70305-0.
38. Kamarulzaman, A., Altice, F.L., Challenges in managing HIV in people who use drugs. Current Opinion in Infectious Diseases 28:1 (2015), 10–16, 10.1097/QCO.0000000000000125.
39. Kavasery, R., Maru, D.S., Cornman-Homonoff, J., Sylla, L.N., Smith, D., Altice, F.L., Routine opt-out HIV testing strategies in a female jail setting: A prospective controlled trial. PLoS ONE, 4(11), 2009, e7648, 10.1371/journal.pone.0007648.
40. Kavasery, R., Maru, D.S., Sylla, L.N., Smith, D., Altice, F.L., A prospective controlled trial of routine opt-out HIV testing in a men's jail. PLoS ONE, 4(11), 2009, e8056, 10.1371/journal.pone.0008056.
41. Kinlock, T.W., Gordon, M.S., Schwartz, R.P., Fitzgerald, T.T., O'Grady, K.E., A randomized clinical trial of methadone maintenance for prisoners: Results at 12 months postrelease. Journal of Substance Abuse Treatment 37:3 (2009), 277–285, 10.1016/j.jsat.2009.03.002 pii:S0740-5472(09)00030-0.
42. Larsen, S.A., Steiner, B.M., Rudolph, A.H., Laboratory diagnosis and interpretation of tests for syphilis. Clinical Microbiology Reviews 8:1 (1995), 1–21.
43. Latypov, A., Rhodes, T., Reynolds, L., Prohibition, stigma and violence against men who have sex with men: Effects on HIV in Central Asia. Central Asian Survey 32:1 (2013), 52–65.
44. Lucas, G.M., Chaudhry, A., Hsu, J., Woodson, T., Lau, B., Olsen, Y., et al. Clinic-based treatment of opioid-dependent HIV-infected patients versus referral to an opioid treatment program: A randomized trial. Annals of Internal Medicine 152:11 (2010), 704–711, 10.1059/0003-4819-152-11-201006010-00003 pii:152/11/704.
45. Lumley, T., Analysis of complex survey samples. Journal of Statistical Software 9:1 (2004), 1–19.
46. Lynn, W.A., Lightman, S., Syphilis and HIV: A dangerous combination. Lancet Infectious Diseases 4:7 (2004), 456–466, 10.1016/S1473-3099(04)01061-8.
47. MacGowan, R., Margolis, A., Richardson-Moore, A., Twang, T., Lalota, M.P.T.F., Team, T.R.T.i.C.R., Voluntary rapid human immunodeficiency virus (HIV) testing in jails. Sexually Transmitted Diseases 36:2 (2009), S9–S13.
48. Maru, D.S., Basu, S., Altice, F.L., HIV control efforts should directly address incarceration. Lancet Infectious Diseases 7:9 (2007), 568–569, 10.1016/S1473-3099(07)70190-1 pii:S1473-3099(07)70190-1.
49. Metzger, D.S., Woody, G.E., McLellan, A.T., O'Brien, C.P., Druley, P., Navaline, H., et al. Human immunodeficiency virus seroconversion among intravenous drug users in- and out-of-treatment: An 18-month prospective follow-up. Journal of Acquired Immune Deficiency Syndromes 6:9 (1993), 1049–1056.
50. Ministry of Education Science of the Kyrgyz Republic, Report of the Ministry of Education and Science of the Kyrgyz Republic. Paper presented at the regional conference on HIV prevention and health promotion in the educational environment, Almaty Kazakhstan, 2011.
51. Ministry of Health of the Kyrgyz Republic, Kyrgyz Republic: National report on monitoring progress towards the UNGASS declaration of commitment on HIV/AIDS Reporting Period: January–December. 2014 Retrieved from Bishkek, Kyrgyzstan.
52. Ministry of Health of the Kyrgyz Republic, Rezul'taty dozornogo epidemiologicheskogo nadzora za VIH-infetsiei sredi osuzhdennykh v Kyrgyzskoi Respublike. 2014 Retrieved from Bishkek Kyrgyzstan.
53. Nashkhoev, M., Sergeyev, B., AIDS in the commonwealth of independent states. 2008 Retrieved from Geneva.
54. Palepu, A., Tyndall, M.W., Joy, R., Kerr, T., Wood, E., Press, N., et al. Antiretroviral adherence and HIV treatment outcomes among HIV/HCV co-infected injection drug users: The role of methadone maintenance therapy. Drug and Alcohol Dependence 84:2 (2006), 188–194, 10.1016/j.drugalcdep.2006.02.003.
55. Pitpitan, E.V., Goodman-Meza, D., Burgos, J.L., Abramovitz, D., Chavarin, C.V., Torres, K., et al. Prevalence and correlates of HIV among men who have sex with men in Tijuana, Mexico. Journal of the International AIDS Society, 18, 2015, 19304, 10.7448/IAS.18.1.19304.
56. Platt, L., Rhodes, T., Judd, A., Koshkina, E., Maksimova, S., Latishevskaya, N., et al. Effects of sex work on the prevalence of syphilis among injection drug users in 3 Russian cities. American Journal of Public Health 97:3 (2007), 478–485, 10.2105/AJPH. 2005.069732.
57. Rich, J.D., McKenzie, M., Larney, S., Wong, J.B., Tran, L., Clarke, J., et al. Methadone continuation versus forced withdrawal on incarceration in a combined US prison and jail: A randomised, open-label trial. Lancet 386:9991 (2015), 350–359, 10.1016/S0140-6736(14)62338-2.
58. Rich, J.D., McKenzie, M., Larney, S., Wong, J.B., Tran, L., Clarke, J., et al. Methadone continuation versus forced withdrawal on incarceration in a combined US prison and jail: A randomised, open-label trial. Lancet, 2015, 10.1016/S0140-6736(14)62338-2.
59. Riedner, G., Dehne, K.L., Gromyko, A., Recent declines in reported syphilis rates in eastern Europe and central Asia: Are the epidemics over?. Sexually Transmitted Infections 76:5 (2000), 363–365 Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/11141852.
60. Rosen, D.L., Wohl, D.A., Golin, C.E., Rigdon, J., May, J., White, B.L., et al. Comparing HIV case detection in prison during opt-in vs. opt-out testing policies. Journal of Acquired Immune Deficiency Syndromes, 2015, 10.1097/QAI.0000000000000889.
61. Saunders, J.B., Aasland, O.G., Babor, T.F., de la Fuente, J.R., Grant, M., Development of the alcohol use disorders identification test (AUDIT): WHO collaborative project on early detection of persons with harmful alcohol consumption – II. Addiction 88:6 (1993), 791–804 Retrieved from http://onlinelibrary.wiley.com/store/10.1111/j.1360-0443.1993.tb02093.x/asset/j.1360-0443.1993.tb02093.x.pdf?v=1&t=i95hn95h&s=a1cedabbee802207e7667fd4795066d109e41f05.
62. Schonning, S., Stuikyte, R., Needs assessment report for the Central Asian Training and Information Centre on Harm Reduction. 2009.
63. Shrestha, R.K., Sansom, S.L., Richardson-Moore, A., French, P.T., Scalco, B., Lalota, M., et al. Costs of voluntary rapid HIV testing and counseling in jails in 4 states – Advancing HIV Prevention Demonstration Project, 2003–2006. Sexually Transmitted Diseases 36:2 (Suppl.) (2009), S5–S8.
64. Singer, M., Clair, S., Syndemics and public health: Reconceptualizing disease in bio-social context. Medical Anthropology Quarterly 17:4 (2003), 423–441 Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/14716917.
65. Spicer, N., Bogdan, D., Brugha, R., Harmer, A., Murzalieva, G., Semigina, T., ’It's risky to walk in the city with syringes’: Understanding access to HIV/AIDS services for injecting drug users in the former Soviet Union countries of Ukraine and Kyrgyzstan. Global Health, 7, 2011, 22, 10.1186/1744-8603-7-22.
66. Springer, S.A., Chen, S., Altice, F.L., Improved HIV and substance abuse treatment outcomes for released HIV-infected prisoners: the impact of buprenorphine treatment. J Urban Health 87:4 (2010), 592–602, 10.1007/s11524-010-9438-4.
67. Springer, S.A., Spaulding, A.C., Meyer, J.P., Altice, F.L., Public health implications for adequate transitional care for HIV-infected prisoners: Five essential components. Clinical Infectious Diseases 53:5 (2011), 469–479, 10.1093/cid/cir446.
68. Strathdee, S.A., Lozada, R., Martinez, G., Vera, A., Rusch, M., Nguyen, L., et al. Social and structural factors associated with HIV infection among female sex workers who inject drugs in the Mexico-US border region. PLoS ONE, 6(4), 2011, e19048, 10.1371/journal.pone.0019048.
69. Suresh, K., Thomas, S.V., Suresh, G., Design, data analysis and sampling techniques for clinical research. Annals of Indian Academy of Neurology 14:4 (2011), 287–290, 10.4103/0972-2327.91951.
70. Thorne, C., Ferencic, N., Malyuta, R., Mimica, J., Niemiec, T., Central Asia: Hotspot in the worldwide HIV epidemic. Lancet Infectious Diseases 10:7 (2010), 479–488, 10.1016/S1473-3099(10)70118-3.
71. Uhlmann, S., Milloy, M.J., Kerr, T., Zhang, R., Guillemi, S., Marsh, D., et al. Methadone maintenance therapy promotes initiation of antiretroviral therapy among injection drug users. Addiction 105:5 (2010), 907–913, 10.1111/j.1360-0443.2010.02905.x.
72. United Nations Office on Drugs and Crime (UNODC), Alternatives to incarceration: Custodial and non-custodial measures Vienna. 2006.
73. United Nations Office on Drugs and Crime (UNODC), Drug dependence treatment: Interventions for drug users in prison. 2012 Retrieved from Vienna, Austria.
74. Uuskula, A., Puur, A., Toompere, K., DeHovitz, J., Trends in the epidemiology of bacterial sexually transmitted infections in eastern Europe, 1995–2005. Sexually Transmitted Infections 86:1 (2010), 6–14, 10.1136/sti.2009.037044.
75. Vagenas, P., Azbel, L., Polonsky, M., Kerimi, N., Mamyrov, M., Dvoryak, S., et al. A review of medical and substance use co-morbidities in Central Asian prisons: Implications for HIV prevention and treatment. Drug and Alcohol Dependence 132:Suppl. 1 (2013), S25–S31, 10.1016/j.drugalcdep.2013.07.010.
76. Vitek, C.R., Cakalo, J.I., Kruglov, Y.V., Dumchev, K.V., Salyuk, T.O., Bozicevic, I., et al. Slowing of the HIV epidemic in Ukraine: Evidence from case reporting and key population surveys, 2005–2012. PLOS ONE, 9(9), 2014, e103657, 10.1371/journal.pone.0103657.
77. Walsh, N., Maher, L., HIV and HCV among people who inject drugs in Central Asia. Drug and Alcohol Dependence 132:Suppl. 1 (2013), S37–S40, 10.1016/j.drugalcdep.2013.06.030.
78. Ware, J.E. Jr., Sherbourne, C.D., The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Medical Care 30:6 (1992), 473–483 Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/1593914.
79. Ware, J.E. Jr., Keller, S.D., Gandek, B., Brazier, J.E., Sullivan, M., Evaluating translations of health status questionnaires. Methods from the IQOLA project, International Quality of Life Assessment. International Journal of Technology Assessment in Health Care 11:3 (1995), 525–551 Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/7591551.
80. WHO/UNODC/UNAIDS, Effectivness of Interventions to Address HIV in Prisons, Geneva. 2007.
81. WHO/UNODC/UNAIDS, Policy guidelines for collaborative TB and HIV services for injecting and other drug users: An integrated approach. 2008 http://whqlibdoc.who.int/publications/2008/9789241596930_eng.pdf Accessed 16.12.08.
82. Wickersham, J.A., Zahari, M.M., Azar, M.M., Kamarulzaman, A., Altice, F.L., Methadone dose at the time of release from prison significantly influences retention in treatment: Implications from a pilot study of HIV-infected prisoners transitioning to the community in Malaysia. Drug and Alcohol Dependence 132:1–2 (2013), 378–382, 10.1016/j.drugalcdep.2013.01.005.
83. Wolitski, R.J., Relative efficacy of a multisession sexual risk-reduction intervention for young men released from prisons in 4 states. American Journal of Public Health 96:10 (2006), 1854–1861.
84. World Health Organization, Global tuberculosis report 2012. 2012 Retrieved from Geneva, Switzlerland.
85. World Health Organization (WHO), Consolidated guidelines on HIV prevention, diagnosis and treatment and care for key populations. 2014 Geneva Switzerland, Retrieved from http://apps.who.int/iris/bitstream/10665/128048/1/9789241507431_eng.pdf?ua=1.
86. World Health Organization (WHO), HIV in prisons. 2015 Retrieved from http://www.euro.who.int/en/health-topics/communicable-diseases/hivaids/policy/policy-guidance-for-key-populations-most-at-risk2/hiv-in-prisons Accessed August 7.
87. Zaller, N., Dawalt, M., Beckwith, C., Rich, J.D., Flanigan, T.P., Routine HIV testing in US prisons. Lancet Infectious Diseases 7:7 (2007), 440–441.
88. Zung, W.W., A rating instrument for anxiety disorders. Psychosomatics 12:6 (1971), 371–379, 10.1016/S0033-3182(71)71479-0.